Categories: News

Yakima Chief Hops Launches Latest Pink Boots Blend, Strengthening Education and Gender Diversity in Fermentation

YAKIMA, Wash., Dec. 9, 2025 /PRNewswire/ — Yakima Chief Hops (YCH) in partnership with the Pink Boots Society (PBS), is proud to release the latest Pink Boots Blend, created to support women and non-binary individuals in the fermentation industry through education and professional support.

- Advertisement -

The 9th Annual Pink Boots Blend will be comprised of Ekuanot®, Centennial, HBC 638, and Mosaic®! This year’s blend combines tropical citrus and stone fruit notes with herbal and woody accents for a vibrant fruit medley complemented by a soft undertone of white tea and cedar.  “By offering both expressive citrus and grounding base characteristics, the blend empowers brewers to explore flavor in ways that feel both approachable and innovative,” says YCH Sensory Coordinator Dominic Wise. “There’s a soft, delicate aspect to this year’s blend that we’re excited about and think brewers will too.”

- Advertisement -

YCH will donate $1 from every pound of the blend sold directly to PBS, funding scholarships, training, and professional opportunities for all members. “As the industry shifts, the Pink Boots Blend gives producers of every size a way to stay creative and stay connected. It’s not about the scale of participation, it’s about the commitment to keep innovating together,” says PBS Executive Director, Georgina Solis. “Its impact reaches far beyond flavor; it strengthens the entire industry and contributes to professional development for women and non-binary talent.”

- Advertisement -

With over two thousand members across 31 countries, the Pink Boots Society’s mission is clear: support women and non-binary individuals in the rapidly growing fermentation and alcoholic beverage industry to advance their careers through education. The Pink Boots Blend directly supports this mission and gives brewers (and other makers) a high-quality product that opens the door to creative possibilities! Learn more about the Pink Boots Blend at www.yakimachief.com/commercial/hop-wire/9th-annual-pink-boots-blend. For general inquiries about the blend or YCH, please contact us at hops@yakimachief.com.

- Advertisement -

Yakima Chief Hops  

- Advertisement -

YCH is a 100% grower-owned global hop supplier with a mission to connect the world’s finest brewers with family hop farms. Operating for over 30 years, we have become leaders in innovation, quality, and customer service. We are a resource for brewers, providing industry-leading research and products. We are advocates of sustainability and meaningful social causes, working to support the communities around us. https://www.yakimachief.com/ 

- Advertisement -

Logo – https://mma.prnewswire.com/media/1016498/Yakima_Chief_Logo.jpg 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/yakima-chief-hops-launches-latest-pink-boots-blend-strengthening-education-and-gender-diversity-in-fermentation-302634529.html

- Advertisement -

Recent Posts

Altius Inspiro Secures Second Consecutive Fortress Cybersecurity Award for Network Security Excellence

MANILA, Philippines, June 20, 2026 (GLOBE NEWSWIRE) -- Altius Inspiro, a global leader in digital…

24 minutes ago

SmallBizSEO Expands SEO Services to Help Local Businesses Increase Visibility Across Google and AI-Powered Search Platforms

Data-backed SEO strategies help local and service-based businesses improve Google rankings, increase AI search visibility,…

24 minutes ago

XPPen Unveils Amazon Prime Day 2026 Deals with Up to 35% Off Drawing Tablets

Shenzhen, China, June 19, 2026 (GLOBE NEWSWIRE) -- Amazon Prime Day 2026 will run from…

24 minutes ago

Glass House Brands Announces Voting Results Following Annual Meeting

June 19, 2026 07:30 ET  | Source: Glass House Brands Inc. LONG BEACH, Calif. and…

4 hours ago

uniQure Announces Preliminary Data on the First Cohort in the Phase I/IIa Clinical Trial of AMT-260 in Refractory Mesial Temporal Lobe Epilepsy

~ AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early…

4 hours ago

Press Release: Sanofis Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma

Sanofi’s Sarclisa subcutaneous formulation approved in Japan for patients with multiple myeloma Approval based on…

4 hours ago